These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8961270)

  • 1. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity.
    Fan JD; Wagner BL; McDonnell DP
    Mol Endocrinol; 1996 Dec; 10(12):1605-16. PubMed ID: 8961270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
    Elgort MG; Zou A; Marschke KB; Allegretto EA
    Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O; Yamagishi T; Hanada K; Kawashima H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.
    Nardulli AM; Romine LE; Carpo C; Greene GL; Rainish B
    Mol Endocrinol; 1996 Jun; 10(6):694-704. PubMed ID: 8776729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells.
    Dana SL; Hoener PA; Wheeler DA; Lawrence CB; McDonnell DP
    Mol Endocrinol; 1994 Sep; 8(9):1193-207. PubMed ID: 7838152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two functional estrogen response elements complexed with AP-1-like sites in the human insulin receptor gene promoter.
    García-Arencibia M; Dávila N; Campión J; Carmen Carranza M; Calle C
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):1-14. PubMed ID: 15862945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R; Porter W; Safe S
    Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.
    Webb P; Nguyen P; Valentine C; Lopez GN; Kwok GR; McInerney E; Katzenellenbogen BS; Enmark E; Gustafsson JA; Nilsson S; Kushner PJ
    Mol Endocrinol; 1999 Oct; 13(10):1672-85. PubMed ID: 10517669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-induced DNA bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence.
    Nardulli AM; Grobner C; Cotter D
    Mol Endocrinol; 1995 Aug; 9(8):1064-76. PubMed ID: 7476980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions.
    Tzukerman MT; Esty A; Santiso-Mere D; Danielian P; Parker MG; Stein RB; Pike JW; McDonnell DP
    Mol Endocrinol; 1994 Jan; 8(1):21-30. PubMed ID: 8152428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts.
    Sasaki-Iwaoka H; Maruyama K; Endoh H; Komori T; Kato S; Kawashima H
    J Bone Miner Res; 1999 Feb; 14(2):248-55. PubMed ID: 9933479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta.
    Shapiro RA; Xu C; Dorsa DM
    Endocrinology; 2000 Nov; 141(11):4056-64. PubMed ID: 11089536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
    McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
    Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element.
    Sukovich DA; Mukherjee R; Benfield PA
    Mol Cell Biol; 1994 Nov; 14(11):7134-43. PubMed ID: 7935428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta.
    Watanabe T; Inoue S; Ogawa S; Ishii Y; Hiroi H; Ikeda K; Orimo A; Muramatsu M
    Biochem Biophys Res Commun; 1997 Jul; 236(1):140-5. PubMed ID: 9223441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
    Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.